Related Experiment Video
Updated: Mar 12, 2026

08:18
Three-Dimensional Reconstruction of Orbital Fractures
Published on: May 16, 2025
814
Integrated versus non-integrated orbital implants for treating anophthalmic sockets
Silvana Schellini1, Regina El Dib, Leandro Re Silva
1Botucatu Medical School, UNESP - Univ Estadual Paulista, Distrito de Rubião Júnior, s/n, Botucatu, São Paulo, Brazil, 18618-970.
The Cochrane Database of Systematic Reviews
|November 8, 2016
Summary
Limited evidence from three small trials suggests integrated and non-integrated orbital implants have similar success rates for anophthalmic socket treatment. Further research is needed to determine optimal implant choices for anophthalmic sockets.
Area of Science:
- Ophthalmology
- Biomaterials Science
- Surgical Innovation
Background:
- Anophthalmia, the absence of one or both eyes, requires orbital implant reconstruction.
- Integrated implants (e.g., hydroxyapatite) integrate with host tissue, while non-integrated implants (e.g., PMMA) remain separate.
- Uncertainties persist regarding the comparative effectiveness of integrated versus non-integrated orbital implants in anophthalmic socket treatment.
Purpose of the Study:
- To systematically assess the effects of integrated versus non-integrated orbital implants in treating anophthalmic sockets.
- To evaluate implant success rates, motility, and adverse events associated with different orbital implant types.
- To identify gaps in current research for anophthalmic socket reconstruction.
Main Methods:
- A comprehensive literature search was conducted across multiple databases (CENTRAL, MEDLINE, Embase, LILACS, ISRCTN, ClinicalTrials.gov, WHO ICTRP) up to August 2016.
- Included randomized controlled trials (RCTs) and quasi-RCTs comparing integrated and non-integrated orbital implants for anophthalmic sockets.
- Data on procedure success, implant motility, and adverse events were independently extracted and analyzed by two authors.
Main Results:
- Three heterogeneous RCTs with 284 participants were included; analysis focused on 250 participants.
- No significant difference in the proportion of successful procedures at one year was found between integrated (hydroxyapatite) and non-integrated (alloplastic) implants (low-certainty evidence).
- Evidence regarding implant motility showed mixed results, with some indications of slightly worse mobility with integrated implants, but differences in surgical techniques complicate attribution (very low-certainty evidence). Adverse events were inconsistently reported.
Conclusions:
- Current evidence from three small RCTs is insufficient to definitively assess the effects of integrated versus non-integrated orbital implants for anophthalmic sockets.
- The included studies were generally poorly reported, with an unclear risk of bias.
- Further well-designed randomized controlled trials are crucial to guide clinical decisions in anophthalmic socket treatment.
Related Concept Videos
Ophthalmic Drug Delivery Systems
154
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
154
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K

